JP2008534522A5 - - Google Patents

Download PDF

Info

Publication number
JP2008534522A5
JP2008534522A5 JP2008503332A JP2008503332A JP2008534522A5 JP 2008534522 A5 JP2008534522 A5 JP 2008534522A5 JP 2008503332 A JP2008503332 A JP 2008503332A JP 2008503332 A JP2008503332 A JP 2008503332A JP 2008534522 A5 JP2008534522 A5 JP 2008534522A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
manufacturing
disorders
pharmaceutical
bed drying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008503332A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008534522A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2006/000470 external-priority patent/WO2006102750A1/en
Publication of JP2008534522A publication Critical patent/JP2008534522A/ja
Publication of JP2008534522A5 publication Critical patent/JP2008534522A5/ja
Pending legal-status Critical Current

Links

JP2008503332A 2005-03-30 2006-03-30 医薬組成物のための複合ステップ製造方法 Pending JP2008534522A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2505463 2005-03-30
PCT/CA2006/000470 WO2006102750A1 (en) 2005-03-30 2006-03-30 Combined-step process for pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2008534522A JP2008534522A (ja) 2008-08-28
JP2008534522A5 true JP2008534522A5 (enExample) 2009-04-02

Family

ID=37052908

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008503332A Pending JP2008534522A (ja) 2005-03-30 2006-03-30 医薬組成物のための複合ステップ製造方法

Country Status (5)

Country Link
US (1) US8216611B2 (enExample)
EP (1) EP1871363A4 (enExample)
JP (1) JP2008534522A (enExample)
AU (1) AU2006228947A1 (enExample)
WO (1) WO2006102750A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080014271A1 (en) * 2006-07-13 2008-01-17 Ucb, S.A. Novel pharmaceutical compositions comprising levetiracetam
FR2912056B1 (fr) * 2007-02-05 2009-12-18 Rd Pharmagal Composition a liberation prolongee de levetiracetam et procede de preparation
ATE542525T1 (de) * 2007-10-16 2012-02-15 Pharmathen Sa Verbesserte pharmazeutische zusammensetzung mit einem pyrrolidon-antikonvulsivum und verfahren zu seiner herstellung
JP2010024156A (ja) * 2008-07-16 2010-02-04 Ucb Pharma Sa レベチラセタムを含む医薬組成物
ES2865504T3 (es) * 2008-10-16 2021-10-15 Univ Johns Hopkins Procedimientos y composiciones para la mejora de la función cognitiva
EP2179725A1 (en) * 2008-10-23 2010-04-28 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising levetiracetam
EA037187B1 (ru) * 2010-02-09 2021-02-17 Дзе Джонс Хопкинс Юниверсити Способ и композиция для лечения когнитивного расстройства
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
HK1216513A1 (zh) 2013-03-15 2016-11-18 阿普雷奇亚制药有限责任公司 包含左乙拉西坦的快速分散劑型
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ， インコーポレイテッド 認知機能を改善するための方法および組成物
US9339489B2 (en) 2013-03-15 2016-05-17 Aprecia Pharmaceuticals Company Rapid disperse dosage form containing levetiracetam
AU2016268096B2 (en) 2015-05-22 2021-04-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
JP6422464B2 (ja) * 2016-05-19 2018-11-14 エルメッド エーザイ株式会社 レベチラセタム含有医薬組成物及びその製造方法、並びにレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止方法、及びレベチラセタム含有医薬組成物の崩壊及び溶出の少なくともいずれかの遅延防止剤
JP7264711B2 (ja) * 2019-04-26 2023-04-25 東和薬品株式会社 レベチラセタム含有医薬組成物の製造方法
CN115350178B (zh) * 2022-08-24 2024-04-26 浙江京新药业股份有限公司 一种包含左乙拉西坦的药物组合物
CN119679738B (zh) * 2025-02-27 2025-06-20 福安药业集团宁波天衡制药有限公司 一种巴氯芬片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
US5204115A (en) * 1990-12-12 1993-04-20 Suomen Xyrofin Oy Directly compressible xylitol and method
DE19613395A1 (de) * 1996-04-03 1997-10-09 Basf Ag Granulate hygroskopischer, wasserlöslicher Produkte
JPH11319534A (ja) * 1998-03-18 1999-11-24 Hosokawa Micron Corp 造粒装置
JP2000281561A (ja) * 1999-03-26 2000-10-10 Ajinomoto Co Inc 新規溶媒法固体分散体製剤
RS50262B2 (sr) * 1999-08-31 2018-10-31 Bayer Pharma AG Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva
US6264983B1 (en) * 1999-09-16 2001-07-24 Rhodia, Inc. Directly compressible, ultra fine acetaminophen compositions and process for producing same
YU37602A (sh) 1999-12-01 2005-07-19 Ucb S.A. Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns
EP1118321A1 (fr) * 2000-01-14 2001-07-25 Ucb, S.A. Compositions pharmaceutiques solides pour la libération contrôlée de substances actives
JP4039782B2 (ja) * 2000-02-15 2008-01-30 小川香料株式会社 粉末酸味料組成物及びその製造方法
US20010053791A1 (en) * 2000-03-16 2001-12-20 Babcock Walter C. Glycogen phosphorylase inhibitor
DE10224170A1 (de) 2002-05-31 2003-12-11 Desitin Arzneimittel Gmbh Pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreisetzung
JPWO2004037293A1 (ja) * 2002-10-22 2006-02-23 大日本住友製薬株式会社 安定化組成物
EP1517893A2 (en) 2003-02-03 2005-03-30 Teva Pharmaceutical Industries Limited Process for producing levetiracetam
CA2525366A1 (en) 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
NZ556630A (en) 2005-01-27 2010-12-24 Alembic Ltd Extended release formulation of levetiracetam including a hydrophilic rate controlling polymer
US8431156B2 (en) 2005-02-22 2013-04-30 Sun Pharma Advanced Research Company Ltd. Pharmaceutical composition

Similar Documents

Publication Publication Date Title
JP2008534522A5 (enExample)
AU2024201739B2 (en) Dosage forms of controlled release at specific gastrointestinal sites
ES2548886T3 (es) Comprimidos bicapa que comprenden elvitegravir, cobicistat, emtricitabina y tenofovir
HRP20100674T1 (hr) Farmaceutski pripravak koji sadrzi omega-karboksiaril supstituirani difenil ureu za lijecenje raka
US20120093738A1 (en) Taste-masked oral formulations of influenza antivirals
CN101283991B (zh) 口腔崩解剂及其制造方法
ME01458B (me) Kruta dozna forma koja sadrži inhibitor protonske pumpe i njena suspenzija
AU2011316103B2 (en) Phosphate binder formulation for simple ingestion
HRP20250604T1 (hr) Formulacije tableta neratinib maleata
WO1999047124A1 (en) Tablets quickly disintegrating in the oral cavity and process for producing the same
JP7336388B2 (ja) 錠剤及びその製造方法
WO2002069933A1 (fr) Comprimés à délitement rapide dans la bouche
JP2006527184A5 (enExample)
JP2009537478A5 (enExample)
JP2022153638A5 (enExample)
WO2012173581A4 (en) Thiocolchicoside, etodolac and famotidine combinations
JP2018526345A5 (enExample)
WO2009084041A3 (en) Pharmaceutical compositions of dexibuprofen
WO2011121823A1 (ja) 経口投与用粒子状医薬組成物
JP2009508916A5 (enExample)
JP6164346B2 (ja) 口腔内崩壊錠の製造方法
JP5062872B2 (ja) 不快な味を低減した口腔内崩壊錠剤
CA2462905A1 (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis and crohn's disease
JP2008500287A5 (enExample)
JP2013237651A (ja) ピタバスタチンの口腔内崩壊錠